Akums Drugs and Pharmaceuticals Pre-IPO - Profitable but Needs to Scale up More
293 Views24 Jul 2024 11:30
Akums Drugs and Pharmaceuticals (0200361D IN) is looking to raise up to US$239m in its upcoming India IPO. In this note, we talk about the company’s historical performance.
What is covered in the Full Insight:
- Company Background
- Revenue Drivers
- Client Base and Relationships
- Industry Growth and Government Support
- Financial Performance and Risks
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 7-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Akums Drugs and Pharmaceuticals IPO Trading - Strong Demand and a Decent Margin of Safety05 Aug 2024
- Akums Drugs and Pharmaceuticals IPO: Subscribe on Favorable Industry Tailwind and Reasonable Pricing26 Jul 2024
- Akums Drugs and Pharmaceuticals IPO - RHP Updates & Quick Thoughts on Peer Comp and Valuation26 Jul 2024
- Akums Drugs and Pharmaceuticals Pre-IPO Tearsheet26 Feb 2024
x